These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

521 related articles for article (PubMed ID: 23433573)

  • 1. Use of low-density lipoprotein cholesterol gene score to distinguish patients with polygenic and monogenic familial hypercholesterolaemia: a case-control study.
    Talmud PJ; Shah S; Whittall R; Futema M; Howard P; Cooper JA; Harrison SC; Li K; Drenos F; Karpe F; Neil HA; Descamps OS; Langenberg C; Lench N; Kivimaki M; Whittaker J; Hingorani AD; Kumari M; Humphries SE
    Lancet; 2013 Apr; 381(9874):1293-301. PubMed ID: 23433573
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Refinement of variant selection for the LDL cholesterol genetic risk score in the diagnosis of the polygenic form of clinical familial hypercholesterolemia and replication in samples from 6 countries.
    Futema M; Shah S; Cooper JA; Li K; Whittall RA; Sharifi M; Goldberg O; Drogari E; Mollaki V; Wiegman A; Defesche J; D'Agostino MN; D'Angelo A; Rubba P; Fortunato G; Waluś-Miarka M; Hegele RA; Aderayo Bamimore M; Durst R; Leitersdorf E; Mulder MT; Roeters van Lennep JE; Sijbrands EJ; Whittaker JC; Talmud PJ; Humphries SE
    Clin Chem; 2015 Jan; 61(1):231-8. PubMed ID: 25414277
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinical utility of the polygenic LDL-C SNP score in familial hypercholesterolemia.
    Futema M; Bourbon M; Williams M; Humphries SE
    Atherosclerosis; 2018 Oct; 277():457-463. PubMed ID: 30270085
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Greater preclinical atherosclerosis in treated monogenic familial hypercholesterolemia vs. polygenic hypercholesterolemia.
    Sharifi M; Higginson E; Bos S; Gallivan A; Harvey D; Li KW; Abeysekera A; Haddon A; Ashby H; Shipman KE; Cooper JA; Futema M; Roeters van Lennep JE; Sijbrands EJG; Labib M; Nair D; Humphries SE
    Atherosclerosis; 2017 Aug; 263():405-411. PubMed ID: 28549500
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Genetic Architecture of Familial Hypercholesterolaemia.
    Sharifi M; Futema M; Nair D; Humphries SE
    Curr Cardiol Rep; 2017 May; 19(5):44. PubMed ID: 28405938
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The familial hypercholesterolaemia phenotype: Monogenic familial hypercholesterolaemia, polygenic hypercholesterolaemia and other causes.
    Mariano C; Alves AC; Medeiros AM; Chora JR; Antunes M; Futema M; Humphries SE; Bourbon M
    Clin Genet; 2020 Mar; 97(3):457-466. PubMed ID: 31893465
    [TBL] [Abstract][Full Text] [Related]  

  • 7. LDL-C Concentrations and the 12-SNP LDL-C Score for Polygenic Hypercholesterolaemia in Self-Reported South Asian, Black and Caribbean Participants of the UK Biobank.
    Gratton J; Finan C; Hingorani AD; Humphries SE; Futema M
    Front Genet; 2022; 13():845498. PubMed ID: 35432461
    [No Abstract]   [Full Text] [Related]  

  • 8. Polygenic Contribution to Low-Density Lipoprotein Cholesterol Levels and Cardiovascular Risk in Monogenic Familial Hypercholesterolemia.
    Trinder M; Paquette M; Cermakova L; Ban MR; Hegele RA; Baass A; Brunham LR
    Circ Genom Precis Med; 2020 Oct; 13(5):515-523. PubMed ID: 33079599
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Twelve Variants Polygenic Score for Low-Density Lipoprotein Cholesterol Distribution in a Large Cohort of Patients With Clinically Diagnosed Familial Hypercholesterolemia With or Without Causative Mutations.
    Olmastroni E; Gazzotti M; Arca M; Averna M; Pirillo A; Catapano AL; Casula M;
    J Am Heart Assoc; 2022 Apr; 11(7):e023668. PubMed ID: 35322671
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Polygenic risk scores for low-density lipoprotein cholesterol and familial hypercholesterolemia.
    Nomura A; Sato T; Tada H; Kannon T; Hosomichi K; Tsujiguchi H; Nakamura H; Takamura M; Tajima A; Kawashiri MA
    J Hum Genet; 2021 Nov; 66(11):1079-1087. PubMed ID: 33967275
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mutation spectrum and polygenic score in German patients with familial hypercholesterolemia.
    Rieck L; Bardey F; Grenkowitz T; Bertram L; Helmuth J; Mischung C; Spranger J; Steinhagen-Thiessen E; Bobbert T; Kassner U; Demuth I
    Clin Genet; 2020 Nov; 98(5):457-467. PubMed ID: 32770674
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Single Nucleotide Variants Associated With Polygenic Hypercholesterolemia in Families Diagnosed Clinically With Familial Hypercholesterolemia.
    Lamiquiz-Moneo I; Pérez-Ruiz MR; Jarauta E; Tejedor MT; Bea AM; Mateo-Gallego R; Pérez-Calahorra S; Baila-Rueda L; Marco-Benedí V; de Castro-Orós I; Cenarro A; Civeira F
    Rev Esp Cardiol (Engl Ed); 2018 May; 71(5):351-356. PubMed ID: 28919240
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Whole-Genome Sequencing to Characterize Monogenic and Polygenic Contributions in Patients Hospitalized With Early-Onset Myocardial Infarction.
    Khera AV; Chaffin M; Zekavat SM; Collins RL; Roselli C; Natarajan P; Lichtman JH; D'Onofrio G; Mattera J; Dreyer R; Spertus JA; Taylor KD; Psaty BM; Rich SS; Post W; Gupta N; Gabriel S; Lander E; Ida Chen YD; Talkowski ME; Rotter JI; Krumholz HM; Kathiresan S
    Circulation; 2019 Mar; 139(13):1593-1602. PubMed ID: 30586733
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A Belgian consensus strategy to identify familial hypercholesterolaemia in the coronary care unit and its subsequent cascade screening and treatment: BEL-FaHST (The BELgium Familial Hypercholesterolaemia STrategy).
    Descamps OS; Van Caenegem O; Hermans MP; Balligand JL; Beauloye C; Bondue A; Carlier S; Castermans E; Chenot F; Claeys M; De Block C; de Leener A; De Meester A; Demeure F; De Raedt H; Desmet W; Elegeert I; Guillaume M; Hoffer E; Kacenelenbogen R; Lancellotti P; Langlois M; Leone A; Mertens A; Paquot N; Vanakker O; Vanoverschelde JL; Verhaegen A; Vermeersch P; Wallemacq C; Rietzschel E;
    Atherosclerosis; 2018 Oct; 277():369-376. PubMed ID: 30270073
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Causative mutations and premature cardiovascular disease in patients with heterozygous familial hypercholesterolaemia.
    Rubba P; Gentile M; Marotta G; Iannuzzi A; Sodano M; De Simone B; Jossa F; Iannuzzo G; Giacobbe C; Di Taranto MD; Fortunato G
    Eur J Prev Cardiol; 2017 Jul; 24(10):1051-1059. PubMed ID: 28353356
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Improving the cost-effectiveness equation of cascade testing for familial hypercholesterolaemia.
    Pears R; Griffin M; Futema M; Humphries SE
    Curr Opin Lipidol; 2015 Jun; 26(3):162-8. PubMed ID: 25887683
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Familial hypercholesterolemia: is it time to separate monogenic from polygenic familial hypercholesterolemia?
    Brandts J; Dharmayat KI; Ray KK; Vallejo-Vaz AJ
    Curr Opin Lipidol; 2020 Jun; 31(3):111-118. PubMed ID: 32332432
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clinical experience of scoring criteria for Familial Hypercholesterolaemia (FH) genetic testing in Wales.
    Haralambos K; Whatley SD; Edwards R; Gingell R; Townsend D; Ashfield-Watt P; Lansberg P; Datta DB; McDowell IF
    Atherosclerosis; 2015 May; 240(1):190-6. PubMed ID: 25797312
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Homozygous familial hypercholesterolaemia in Vietnam: Case series, genetics and cascade testing of families.
    Truong TH; Kim NT; Nguyen MNT; Pang J; Hooper AJ; Watts GF; Do DL
    Atherosclerosis; 2018 Oct; 277():392-398. PubMed ID: 30270076
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Parent-child genetic testing for familial hypercholesterolaemia in an Australian context.
    Pang J; Martin AC; Bates TR; Hooper AJ; Bell DA; Burnett JR; Norman R; Watts GF
    J Paediatr Child Health; 2018 Jul; 54(7):741-747. PubMed ID: 29626384
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 27.